Alphatec Holdings, Inc. ATEC

FY2025 · ended Dec 31, 2025 · Revenue $764.15M, +25.0% YoY · Filed Feb 24, 2026

Alphatec Holdings, Inc. (ATEC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $764.2 million and a net loss of $143.4 million. Free cash flow was $2.8 million. As of Sep 30, 2026 it held $79.9 million in cash and investments and $599.2 million in total debt.

Revenue (TTM)
$839.72M
+15.3% vs year-ago TTM
Net income (TTM)
$-86.89M
+43.9% vs year-ago TTM
Operating cash flow (TTM)
$61.34M
+74.9% vs year-ago TTM
Free cash flow (TTM)
$3.07M
-15.0% vs year-ago TTM
EPS (TTM)
$-0.56
+46.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
151.36M
+5.0% vs prior year
Net cash
$-519.31M
as of Sep 30, 2026
Operating margin
-3.6%
FY 2026

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ATEC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
Large accelerated filer
SEC CIK
1350653
Former names
Alphatec Holdings, Inc. (until Nov 2, 2026)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$764.2M
$611.6M
$482.3M
$350.9M
$243.2M
Operating income
-$82.1M
-$136.2M
-$173.4M
-$147.0M
-$128.1M
Net income
-$143.4M
-$162.1M
-$186.6M
-$151.3M
-$143.0M
Diluted EPS
-$0.96
-$1.13
-$1.54
-$1.46
—
Operating cash flow
$45.2M
-$44.7M
-$78.5M
-$75.1M
-$73.3M
Free cash flow
$2.8M
-$127.9M
-$159.0M
-$124.6M
-$141.9M
Total assets
$791.2M
$775.7M
$805.2M
$521.0M
$572.1M
Stockholders' equity
$12.4M
-$14.2M
$78.1M
-$34.7M
$80.7M
Cash and investments
$160.8M
$138.8M
$221.0M
$84.7M
$187.2M
Total debt
$660.6M
$611.6M
$543.5M
$410.8M
$355.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 10, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.